Intra-Cellular Therapies, Inc. Quarterly Revenues in USD from Q3 2012 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Revenues history and growth rate from Q3 2012 to Q4 2022.
  • Intra-Cellular Therapies, Inc. Revenues for the quarter ending December 31, 2022 was $87.9M, a 242% increase year-over-year.
  • Intra-Cellular Therapies, Inc. Revenues for the twelve months ending December 31, 2022 was $250M, a 199% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Revenues for 2017 was $246K, a 25.7% decline from 2016.
  • Intra-Cellular Therapies, Inc. annual Revenues for 2016 was $331K, a 262% increase from 2015.
  • Intra-Cellular Therapies, Inc. annual Revenues for 2015 was $91.4K, a 84.2% decline from 2014.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $250M $87.9M +$62.2M +242% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $188M $71.9M +$49.7M +224% Jul 1, 2022 Sep 30, 2022 10-K 2023-03-01
Q2 2022 $138M $55.6M +$35.5M +177% Apr 1, 2022 Jun 30, 2022 10-K 2023-03-01
Q1 2022 $103M $35M +$19.1M +120% Jan 1, 2022 Mar 31, 2022 10-K 2023-03-01
Q4 2021 $83.8M $25.7M +$13.2M +106% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $70.6M $22.2M +$14.8M +201% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-01
Q2 2021 $55.7M $20M +$18.1M +951% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-01
Q1 2021 $37.6M $15.9M +$14.8M +1365% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-01
Q4 2020 $22.8M $12.5M +$12.4M +20447% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $10.4M $7.37M Jul 1, 2020 Sep 30, 2020 10-K 2022-03-01
Q2 2020 $1.91M Apr 1, 2020 Jun 30, 2020 10-K 2022-03-01
Q1 2020 $1.08M Jan 1, 2020 Mar 31, 2020 10-K 2022-03-01
Q4 2019 $60.6K Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q4 2017 $246K $5.06K -$92.8K -94.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $339K $30.8K +$26.4K +605% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 $312K $115K -$114K -49.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 $426K $95.3K Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 $97.9K +$67.2K +219% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $4.36K Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 $228K +$171K +298% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q4 2015 $30.7K -$35.2K -53.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q2 2015 $251K $57.4K -$162K -73.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 $413K $3.32K -$164K -98% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 $577K $65.9K -$762K -92% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-25
Q3 2014 $1.34M $124K -$544K -81.4% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 $1.88M $219K -$424K -65.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 $2.31M $168K -$430K -72% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25
Q4 2013 $2.74M $828K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 $668K +$290K +76.7% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 $643K Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 $598K Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q3 2012 $378K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.